Amy Fadia
Analyst
Needham & Company
Equibles does not estimate personal net worth.
About Amy Fadia
Amy Fadia is recorded as Analyst at Needham & Company. Amy Fadia has spoken on 2 earnings calls across 2 companies, most recently for Harmony Biosciences Holdings, Inc. on August 4, 2026. Those appearances were for Harmony Biosciences Holdings, Inc. (HRMY) and Jazz Pharmaceuticals plc (JAZZ). The companies whose calls Amy Fadia spoke on are classified in the Healthcare sector.
Amy Fadia on recent calls
“I had a follow-up on the comments related to the Oxabate franchise, particularly Zyve. I think at the beginning of the year, you talked about anticipating the potential for some additional headwinds, either on pricing side or just, you know, in terms of access with the entry of generics.”
Affiliation history
-
Needham & Company
Analyst
Transcript header (unverified)
Current